open access

Vol 9, No 6 (2005)
Prace oryginalne
Published online: 2005-12-13
Get Citation

Prevalence of metabolic syndrome in patients with essential hypertension - impact of gender

Anna Lakowska, Marzena Chrostowska, Anna Szyndler, Katarzyna Śmiałek, Radosław Szczęch, Tomasz Zdrojewski, Krzysztof Narkiewicz
Nadciśnienie tętnicze 2005;9(6):458-462.

open access

Vol 9, No 6 (2005)
Prace oryginalne
Published online: 2005-12-13

Abstract

Background Metabolic syndrome is associated with increased cardiovascular risk. The aim of the present study was to evaluate prevalence of metabolic syndrome in hypertensive patients with respect to gender.
Material and methods We enrolled 572 patients with essential hypertension (275 females and 297 males). Mean age of the subjects was 53.0 ± 14.6 years (range 18-85 years), and mean body mass index 28.5 ± 5.0 kg/m2. Metabolic syndrome was diagnosed according to ATP III criteria.
Results Abdominal obesity was found in 44,8% of the patients. Central obesity was detected in 50.9% of females and in 39,2% of males (p < 0.05). At least one component of the syndrome, additional to hypertension, was observed in 66% of females and in 75% of male hypertensives (p < 0.01). Metabolic syndrome, defined by the ATP III criteria, was found in 40,5% of the subjects. Metabolic syndrome (at least 3 criteria) was more prevalent in males (45%) than in females (35%) (p < 0.01).
Conclusions 1. In hypertensive patients, prevalence of metabolic syndrome is increased two-fold in comparison to general population. Relative increase in the prevalence of metabolic syndrome in hypertensives is greater in male than in female patients.
2. There are gender-specific differences in the prevalence of various components of metabolic syndrome in patients with hypertension. While abdominal obesity is more prevalent in females, glucose intolerance, high triglyceride levels and low HDL cholesterol levels are more frequent in male patients with hypertension.

Abstract

Background Metabolic syndrome is associated with increased cardiovascular risk. The aim of the present study was to evaluate prevalence of metabolic syndrome in hypertensive patients with respect to gender.
Material and methods We enrolled 572 patients with essential hypertension (275 females and 297 males). Mean age of the subjects was 53.0 ± 14.6 years (range 18-85 years), and mean body mass index 28.5 ± 5.0 kg/m2. Metabolic syndrome was diagnosed according to ATP III criteria.
Results Abdominal obesity was found in 44,8% of the patients. Central obesity was detected in 50.9% of females and in 39,2% of males (p < 0.05). At least one component of the syndrome, additional to hypertension, was observed in 66% of females and in 75% of male hypertensives (p < 0.01). Metabolic syndrome, defined by the ATP III criteria, was found in 40,5% of the subjects. Metabolic syndrome (at least 3 criteria) was more prevalent in males (45%) than in females (35%) (p < 0.01).
Conclusions 1. In hypertensive patients, prevalence of metabolic syndrome is increased two-fold in comparison to general population. Relative increase in the prevalence of metabolic syndrome in hypertensives is greater in male than in female patients.
2. There are gender-specific differences in the prevalence of various components of metabolic syndrome in patients with hypertension. While abdominal obesity is more prevalent in females, glucose intolerance, high triglyceride levels and low HDL cholesterol levels are more frequent in male patients with hypertension.
Get Citation

Keywords

hypertension; obesity; gender; metabolic syndrome

About this article
Title

Prevalence of metabolic syndrome in patients with essential hypertension - impact of gender

Journal

Arterial Hypertension

Issue

Vol 9, No 6 (2005)

Pages

458-462

Published online

2005-12-13

Bibliographic record

Nadciśnienie tętnicze 2005;9(6):458-462.

Keywords

hypertension
obesity
gender
metabolic syndrome

Authors

Anna Lakowska
Marzena Chrostowska
Anna Szyndler
Katarzyna Śmiałek
Radosław Szczęch
Tomasz Zdrojewski
Krzysztof Narkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl